PE Hub -- Durata Therapeutics Inc. formed a senior leadership team. It named Paul R. Edick as chief executive officer, Corey N. Fishman as chief operating officer and Michael Dunne as chief medical officer. Durata is a Morristown, N.J.-based biopharmaceutical company that is backed by Aisling Capital, Canaan Partners, Domain Associates LLC, New Leaf Venture Partners LLC and Sofinnova Ventures Inc.
